Publications by Year: 2008

2008

Chin, Lena J, and Frank J Slack. (2008) 2008. “A Truth Serum for Cancer–microRNAs Have Major Potential As Cancer Biomarkers”. Cell Research 18 (10): 983-4. https://doi.org/10.1038/cr.2008.290.
Pincus, Zachary, and Frank J Slack. (2008) 2008. “Transcriptional (dys)regulation and Aging in Caenorhabditis Elegans”. Genome Biology 9 (9): 233. https://doi.org/10.1186/gb-2008-9-9-233.

A circuit of transcription factors has been discovered in Caenorhabditis elegans that could provide a link between laboratory-defined intracellular 'longevity pathways', gene dysregulation and the process of normal aging.

Chin, Lena J, Elena Ratner, Shuguang Leng, Rihong Zhai, Sunitha Nallur, Imran Babar, Roman-Ulrich Muller, et al. (2008) 2008. “A SNP in a Let-7 MicroRNA Complementary Site in the KRAS 3’ Untranslated Region Increases Non-Small Cell Lung Cancer Risk”. Cancer Research 68 (20): 8535-40. https://doi.org/10.1158/0008-5472.CAN-08-2129.

Lung cancer is the leading cause of cancer deaths worldwide, yet few genetic markers of lung cancer risk useful for screening exist. The let-7 family-of-microRNAs (miRNA) are global genetic regulators important in controlling lung cancer oncogene expression by binding to the 3' untranslated regions of their target mRNAs. The purpose of this study was to identify single nucleotide polymorphisms (SNP) that could modify let-7 binding and to assess the effect of such SNPs on target gene regulation and risk for non-small cell lung cancer (NSCLC). let-7 complementary sites (LCS) were sequenced in the KRAS 3' untranslated region from 74 NSCLC cases to identify mutations and SNPs that correlated with NSCLC. The allele frequency of a previously unidentified SNP at LCS6 was characterized in 2,433 people (representing 46 human populations). The frequency of the variant allele is 18.1% to 20.3% in NSCLC patients and 5.8% in world populations. The association between the SNP and the risk for NSCLC was defined in two independent case-control studies. A case-control study of lung cancer from New Mexico showed a 2.3-fold increased risk (confidence interval, 1.1-4.6; P = 0.02) for NSCLC cancer in patients who smoked <40 pack-years. This association was validated in a second independent case-control study. Functionally, the variant allele results in KRAS overexpression in vitro. The LCS6 variant allele in a KRAS miRANA complementary site is significantly associated with increased risk for NSCLC among moderate smokers and represents a new paradigm for let-7 miRNAs in lung cancer susceptibility.

Schulman, Betsy R Maller, Xianping Liang, Carlos Stahlhut, Casey DelConte, Giovanni Stefani, and Frank J Slack. (2008) 2008. “The Let-7 MicroRNA Target Gene, Mlin41/Trim71 Is Required for Mouse Embryonic Survival and Neural Tube Closure”. Cell Cycle (Georgetown, Tex.) 7 (24): 3935-42.

In the nematode Caenorhabditis elegans, the let-7 microRNA (miRNA) controls the timing of key developmental events and terminal differentiation in part by directly regulating lin-41. C. elegans lin-41 mutants display precocious cell cycle exit and terminal differentiation of epidermal skin cells. lin-41 orthologues are found in more complex organisms including both mice and humans, but their roles are not known. We generated Mlin41 mouse mutants to ascertain a functional role for Mlin41. Strong loss of function Mlin41 gene-trap mutants demonstrated a striking neural tube closure defect during development, and embryonic lethality. Like C. elegans lin-41, Mlin41 also appears to be regulated by the let-7 and mir-125 miRNAs. Since Mlin41 is required for neural tube closure and survival it points to human lin-41 (HLIN41/TRIM71) as a potential human development and disease gene.

Slack, Frank J, and Joanne B Weidhaas. (2008) 2008. “MicroRNA in Cancer Prognosis”. The New England Journal of Medicine 359 (25): 2720-2. https://doi.org/10.1056/NEJMe0808667.
Godshalk, Sirie E, Sumita Bhaduri-McIntosh, and Frank J Slack. (2008) 2008. “Epstein-Barr Virus-Mediated Dysregulation of Human MicroRNA Expression”. Cell Cycle (Georgetown, Tex.) 7 (22): 3595-600.

MicroRNAs (miRNAs) are a large class of small (approximately 22 nt) noncoding RNAs that negatively regulate gene expression most often at the level of translation, and have been shown to be key regulators in a variety of processes including development, cell cycle and immunity. The Epstein-Barr virus (EBV) is an oncogenic herpes virus endemic in humans that encodes at least twenty-two of its own miRNAs. Cellular miRNAs have well-established roles in cancer and immune pathways, and multiple cellular miRNAs directly target viral messages. Additionally, multiple viruses express suppressors of cellular RNAi-induced silencing. Here we show that EBV de novo infection of primary cultured human B-cells results in a dramatic downregulation of cellular miRNA expression, suggesting the virus may encode or activate a suppressor of miRNA expression. We additionally show that the immuno-modulatory microRNA miR-146a, downregulated on initial infection, is significantly upregulated more than 100-fold upon induction of the viral lytic cycle, and appears to have inhibitory effects on the progression of the lytic cycle. Our results show that EBV has substantial effects on cellular miRNA expression.